WHO includes hydroxychloroquine in solidarity trial again
New Delhi: The World Health Organisation on Wednesday said that anti-malarial drug hydroxychloroquine (HCQ) will return to the solidarity trial for the potential treatment of coronavirus disease.
At a press conference in the WHO…